IMCD N.V. (AMS:IMCD)
Netherlands · Delayed Price · Currency is EUR | Market Cap | 6.04B +23.5% |
| Revenue (ttm) | 4.97B +2.7% |
| Net Income | 230.21M -13.7% |
| EPS | 3.90 -14.6% |
| Shares Out | 59.04M |
| PE Ratio | 26.24 |
| Forward PE | 16.45 |
| Dividend | 1.81 (1.77%) |
| Ex-Dividend Date | May 5, 2026 |
| Volume | 163,781 |
| Open | 101.75 |
| Previous Close | 103.05 |
| Day's Range | 101.00 - 102.60 |
| 52-Week Range | 68.14 - 105.55 |
| Beta | 0.98 |
| Analysts | Buy |
| Price Target | 118.29 (+15.63%) |
| Earnings Date | Nov 5, 2026 |
About IMCD N.V.
IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company provides adhesives, core materials, filler reinforcements, flame retardants, masterbatch, modifiers, operating materials, pigments, plasticizers, processing aids, PUR raw materials, rubber elastomers, solvents, stabilizers, thermoplastic elastomers, thermoplastics, thermoplastics, and other additives. It offers actives, UV sunscreens, rheology m... [Read more]
Financial Performance
In 2025, IMCD N.V.'s revenue was 4.81 billion, an increase of 1.23% compared to the previous year's 4.75 billion. Earnings were 217.58 million, a decrease of -21.80%.
Financial StatementsAnalyst Summary
According to 14 analysts, the average rating for IMCD stock is "Buy." The 12-month stock price target is €118.29, which is an increase of 15.63% from the latest price.
News
IMCD N.V. Slides: Investor presentation
IMCD N.V. has posted slides in relation to its latest quarterly earnings report, which was published on November 9, 2026.
IMCD N.V. Earnings Call Transcript: Q3 2026
Nine-month organic gross profit and EBITA growth strengthened through Q3, with strong free cash flow and a positive FY EBITA growth outlook. EMEA and APAC advanced, while Americas remained a recovery priority.
IMCD N.V. Earnings release: Q3 2026
IMCD N.V. released its Q3 2026 earnings on November 5, 2026, summarizing the period's financial results.
IMCD N.V. Slides: Q3 2026
IMCD N.V. has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 5, 2026.
Goldman Sachs names four 'must own' European stocks for 2027
Goldman Sachs has overhauled its flagship European Conviction List – Directors' Cut this month, spotlighting key investment opportunities across the continent heading into 2027. Marking the list's thr...
IMCD N.V. Earnings Call Transcript: Q2 2026
Gross profit and EBITA grew organically in H1 2026, driven by pricing, supplier wins, and acquisitions, with EMEA leading segment performance. Cash flow and leverage remain strong, and early Q3 trends are promising amid dynamic market conditions.
IMCD N.V. Earnings release: Q2 2026
IMCD N.V. released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
IMCD N.V. Slides: Q2 2026
IMCD N.V. has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
IMCD N.V. Slides: Investor presentation
IMCD N.V. has posted slides in relation to its latest quarterly earnings report, which was published on July 28, 2026.
IMCD N.V. Earnings Call Transcript: Q1 2026
Q1 2026 saw modest growth in gross profit and revenue, with strong free cash flow and robust cash conversion. Market volatility from geopolitical events and tariffs led to price increases and cautious outlook, while acquisitions strengthened key segments.
IMCD N.V. Earnings release: Q1 2026
IMCD N.V. released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
IMCD N.V. Slides: Q1 2026
IMCD N.V. has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
IMCD N.V. Slides: Investor presentation
IMCD N.V. has posted slides in relation to its latest quarterly earnings report, which was published on March 5, 2026.
IMCD price target lowered to EUR 119 from EUR 133 at Goldman Sachs
Goldman Sachs lowered the firm’s price target on IMCD (IMDZF) to EUR 119 from EUR 133 and keeps a Buy rating on the shares.
IMCD price target raised to EUR 103 from EUR 93 at Barclays
Barclays raised the firm’s price target on IMCD (IMDZF) to EUR 103 from EUR 93 and keeps an Overweight rating on the shares.
IMCD Shares Plunge After Dividend Cut, Revenue Fall
Shares in the chemicals and food ingredients distributor were down 14%, and the company said waning demand across its markets and regions stalled organic growth in 2025.
IMCD N.V. Earnings Call Transcript: Q4 2025
2025 saw strong early growth but was followed by challenging quarters due to macroeconomic and currency headwinds, leading to softer demand and lower margins. Acquisitions and strategic initiatives supported stability, while management remains cautiously optimistic for 2026.
IMCD N.V. Annual report: Q4 2025
IMCD N.V. has published its Q4 2025 annual report on February 18, 2026.
IMCD N.V. Quarterly report: Q4 2025
IMCD N.V. has published its Q4 2025 quarterly earnings report on February 18, 2026.
IMCD N.V. Slides: Q4 2025
IMCD N.V. has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 18, 2026.
IMCD Colombia to acquire the distribution business of Joli Foods S.A.S. to strengthen its food and nutrition portfolio
ROTTERDAM, The Netherlands (27 December 2023) – IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces that IMC...
IMCD Israel expands its Beauty & Personal Care presence with the acquisition of Tagra Biotechnologies Distribution Division
ROTTERDAM, The Netherlands (1st May 2023) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Israel has acquired the import and...